Prolonged activation of NF-κB by human cytomegalovirus promotes efficient viral replication and late gene expression

Virology

Volumn 346, Issue 1, 2006, Pages 15-31

  DeMeritt, Ian B ^a   Podduturi, Jagat P ^a   Tilley, A Michael ^a   Nogalski, MacIej T ^a   Yurochko, Andrew D ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Aspirin; BAY11; HCMV; Late gene expression; MG 132; MIEP; NF B; Replication

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ACETYLSALICYLIC ACID; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FIBROBLAST; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; PROGENY; SIGNAL TRANSDUCTION; TRANSACTIVATION; VIRUS INFECTIVITY; VIRUS REPLICATION;

ASPIRIN; CELLS, CULTURED; CYTOMEGALOVIRUS; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; LEUPEPTINS; NF-KAPPA B; TIME FACTORS; VIRAL PROTEINS; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 32844462156     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.09.065     Document Type: Article

References (83)

1. S. Aradhya, and D.L. Nelson NF-κB signaling and human disease Curr. Opin. Gen. Dev. 11 2001 300 306
2. A.S. Baldwin Jr. Series introduction: the transcription factor NF-κB and human disease J. Clin. Invest. 107 2001 3 6
3. C.A. Benedict, A. Angulo, G. Patterson, S. Ha, H. Huang, M. Messerle, C.F. Ware, and P. Ghazal Neutrality of the canonical NF-κB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro J. Virol. 78 2004 741 750
4. S.A. Benitah, P.F. Valeron, and J.C. Lacal ROCK and nuclear factor-κB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences Mol. Biol. Cell 14 2003 3041 3054
5. R.A. Blanton, and M.J. Tevethia Immunoprecipitation of virus-specific immediate-early and early polypeptides from cells lytically infected with human cytomegalovirus strain AD 169 Virology 112 1981 262 273
6. A. Blum, M. Giladi, M. Weinberg, G. Kaplan, H. Pasternack, S. Laniado, and H. Miller High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis Am. J. Cardiol. 81 1998 866 868
7. M. Boshart, F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstein, and W. Schaffner A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus Cell 41 1985 521 530
8. W.A. Bresnahan, and T.E. Shenk UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells Proc. Natl. Acad. Sci. U.S.A. 97 2000 14506 14511
9. W.A. Bresnahan, G.E. Hultman, and T. Shenk Replication of wild-type and mutant human cytomegalovirus in life-extended human diploid fibroblasts J. Virol. 74 2000 10816 10818
10. W.J. Britt, and C.A. Alford Cytomegalovirus B.N. Fields D.M. Knipe P.M. Howley Fields Virology third ed. 1996 Lippincott-Raven Publishers Philadelphia, PA 2493 2523
11. C. Bruggeman Cytomegalovirus is involved in vascular pathology Am. Heart J. 138 1999 S473 S475
12. C.A. Bruggeman, H.J. Marjorie, and G. Nelissen-Vrancken Cytomegalovirus and atherogenesis Antivir. Res. 43 1999 135 144
13. E.D. Cahir-McFarland, K. Carter, A. Rosenwald, J.M. Giltnane, S.E. Henrickson, L.M. Staudt, and E. Kieff Role of NF-κB in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells J. Virol. 78 2004 4108 4119
14. P. Caposio, M. Dreano, G. Garotta, G. Gribaudo, and S. Landolfo Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication J. Virol. 78 2004 3190 3195
15. L.F. Chen, and W.C. Greene Shaping the nuclear action of NF-κB Nat. Rev., Mol. Cell Biol. 5 2004 392 401
16. Z. Chen, J. Hagler, V.J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway Genes Dev. 9 1995 1586 1597
17. J.M. Cherrington, and E.S. Mocarski Human cytomegalovirus ie1 transactivates the α promoter-enhancer via an 18-base-pair repeat element J. Virol. 63 1989 1435 1440
18. J.M. Cherrington, E.L. Khoury, and E.S. Mocarski Human cytomegalovirus ie2 negatively regulates α gene expression via a short target sequence near the transcription start site J. Virol. 65 1991 887 896
19. C.S. Crumpacker Cytomegalovirus G.L. Mandell J.E. Bennett R. Dolin 5th ed. Principles and Practice of Infectious Diseases vol. 2 2000 Churchill Livingstone Philadelphia, PA 1586 1599
20. M. Degre Has cytomegalovirus infection any role in the development of atherosclerosis? Clin. Microbiol. Infect. 8 2002 191 195
21. I.B. DeMeritt, L.E. Milford, and A.D. Yurochko Activation of the NF-κB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter J. Virol. 78 2004 4498 4507
22. J. DiDonato, F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation Mol. Cell. Biol. 16 1996 1295 1304
23. J.E. Eickhoff, and M. Cotten NF-κB activation can mediate inhibition of human cytomegalovirus replication J. Gen. Virol. 86 2005 285 295
24. S.E. Epstein, Y.F. Zhou, and J. Zhu Infection and atherosclerosis: emerging mechanistic paradigms Circulation 100 1999 e20 e28
25. S.E. Epstein, Y.F. Zhou, and J. Zhu Potential role of cytomegalovirus in the pathogenesis of restenosis and atherosclerosis Am. Heart J. 138 1999 S476 S478
26. J.M. Gawn, and R.F. Greaves Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression J. Virol. 76 2002 4441 4455
27. C. Gealy, M. Denson, C. Humphreys, B. McSharry, G. Wilkinson, and R. Caswell Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus J. Virol. 79 2005 472 485
28. G. Gerna, D. Zipeto, E. Percivalle, M. Parea, M.G. Revello, R. Maccario, G. Peri, and G. Milanesi Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients J. Infect. Dis. 166 1992 1236 1244
29. R.F. Greaves, and E.S. Mocarski Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant J. Virol. 72 1998 366 379
30. D. Gregory, D. Hargett, D. Holmes, E. Money, and S.L. Bachenheimer Efficient replication by herpes simplex virus type 1 involves activation of the IκB kinase-IκB-p65 pathway J. Virol. 78 2004 13582 13590
31. M.L. Hayashi, C. Blankenship, and T. Shenk Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle Proc. Natl. Acad. Sci. U.S.A. 97 2000 2692 2696
32. J.A. Heider, W.A. Bresnahan, and T.E. Shenk Construction of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein Proc. Natl. Acad. Sci. U.S.A. 99 2002 3141 3146
33. M.G. Hendrix, M.M. Salimans, C.P. van Boven, and C.A. Bruggeman High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis Am. J. Pathol. 136 1990 23 28
34. T.W. Hermiston, C.L. Malone, and M.F. Stinski Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter J. Virol. 64 1990 3532 3536
35. H. Isomura, and M.F. Stinski The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection J. Virol. 77 2003 3602 3614
36. H. Isomura, T. Tsurumi, and M.F. Stinski Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication J. Virol. 78 2004 12788 12799
37. M. Iwata, J. Vieira, M. Byrne, H. Horton, and B. Torok-Storb Interleukin-1 (IL-1) inhibits growth of cytomegalovirus in human marrow stromal cells: inhibition is reversed upon removal of IL-1 Blood 94 1999 572 578
38. R.A. Johnson, X. Wang, X.L. Ma, S.M. Huong, and E.S. Huang Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling J. Virol. 75 2001 6022 6032
39. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-κB activity Annu. Rev. Immunol. 18 2000 621 663
40. J.A. Kerry, M.A. Priddy, and R.M. Stenberg Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products J. Virol. 68 1994 4167 4176
41. E. Klemola, and L. Kaariainen Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis Br. Med. J. 5470 1965 1099 1102
42. E. Kopp, and S. Ghosh Inhibition of NF-κB by sodium salicylate and aspirin Science 265 1994 956 959
43. T.F. Kowalik, B. Wing, J.S. Haskill, J.C. Azizkhan, A.S. Baldwin Jr., and E.S. Huang Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection Proc. Natl. Acad. Sci. U.S.A. 90 1993 1107 1111
44. T.F. Kowalik, A.D. Yurochko, C.A. Rinehart, C.Y. Lee, and E.S. Huang Productive infection of human endometrial stromal cells by human cytomegalovirus Virology 202 1994 247 257
45. B. Liu, T.W. Hermiston, and M.F. Stinski A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2 J. Virol. 65 1991 897 903
46. A. Marchini, H. Liu, and H. Zhu Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes J. Virol. 75 2001 1870 1878
47. J.L. Meier, and J.A. Pruessner The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression J. Virol. 74 2000 1602 1613
48. J.L. Melnick, E. Adam, and M.E. DeBakey Possible role of cytomegalovirus in atherogenesis JAMA 263 1990 2204 2207
49. J.A. Mitchell, M. Saunders, P.J. Barnes, R. Newton, and M.G. Belvisi Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor κB) activation: role of arachidonic acid Mol. Pharmacol. 51 1997 907 912
50. E.S. Mocarski, and C.T. Courcelle Cytomegaloviruses and their replication D.M. Knipe P.M. Howley D.E. Griffin R.A. Lamb M.A. Martin B. Roizman S.E. Straus 4th ed. Fields Virology vol. 2 2001 Lippincott Williams and Wilkins Philadelphia, PA 2629 2673 2 vols
51. E.S. Mocarski, G.W. Kemble, J.M. Lyle, and R.F. Greaves A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation Proc. Natl. Acad. Sci. U.S.A. 93 1996 11321 11326
52. T. Nakayama, K. Hieshima, D. Nagakubo, E. Sato, M. Nakayama, K. Kawa, and O. Yoshie Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus J. Virol. 78 2004 1665 1674
53. P.P. Naranatt, S.M. Akula, C.A. Zien, H.H. Krishnan, and B. Chandran Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-ζ-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity J. Virol. 77 2003 1524 1539
54. V.J. Palombella, O.J. Rando, A.L. Goldberg, and T. Maniatis The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB Cell 78 1994 773 785
55. R.F. Pass Cytomegalovirus D.M. Knipe P.M. Howley D.E. Griffin M.A. Martin R.A. Lamb B. Roizman S.E. Straus 4th ed. Fields Virology vol. 2 2001 Lippincott Williams and Wilkins Philadelphia, PA 2675 2705 2 vols
56. N.D. Perkins The Rel/NF-κB family: friend and foe Trends Biochem. Sci. 25 2000 434 440
57. J.W. Pierce, M.A. Read, H. Ding, F.W. Luscinskas, and T. Collins Salicylates inhibit IκBα phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration J. Immunol. 156 1996 3961 3969
58. J.W. Pierce, R. Schoenleber, G. Jesmok, J. Best, S.A. Moore, T. Collins, and M.E. Gerritsen Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo J. Biol. Chem. 272 1997 21096 21103
59. M.C. Pizzorno, and G.S. Hayward The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site J. Virol. 64 1990 6154 6165
60. M.C. Pizzorno, P. O'Hare, L. Sha, R.L. LaFemina, and G.S. Hayward Trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus J. Virol. 62 1988 1167 1179
61. E.E. Poma, T.F. Kowalik, L. Zhu, J.H. Sinclair, and E.S. Huang The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter J. Virol. 70 1996 7867 7877
62. M.N. Prichard, N. Gao, S. Jairath, G. Mulamba, P. Krosky, D.M. Coen, B.O. Parker, and G.S. Pari A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency J. Virol. 73 1999 5663 5670
63. K. Rosenke, and E.A. Fortunato Bromodeoxyuridine-labeled viral particles as a tool for visualization of the immediate-early events of human cytomegalovirus infection J. Virol. 78 2004 7818 7822
64. L.C. Sambucetti, J.M. Cherrington, G.W. Wilkinson, and E.S. Mocarski NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation EMBO J. 8 1989 4251 4258
65. V. Sanchez, C.L. Clark, J.Y. Yen, R. Dwarakanath, and D.H. Spector Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication J. Virol. 76 2002 2973 2989
66. W.L. Smith, D.L. DeWitt, and E.A. Meade Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs J. Biol. Chem. 268 1993 6610 6614
67. P.D. Sorlie, F.J. Nieto, E. Adam, A.R. Folsom, E. Shahar, and M. Massing A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study Arch. Intern. Med. 160 2000 2027 2032
68. R.M. Stenberg, D.R. Thomsen, and M.F. Stinski Structural analysis of the major immediate early gene of human cytomegalovirus J. Virol. 49 1984 190 199
69. R.M. Stenberg, P.R. Witte, and M.F. Stinski Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1 J. Virol. 56 1985 665 675
70. R.M. Stenberg, A.S. Depto, J. Fortney, and J.A. Nelson Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region J. Virol. 63 1989 2699 2708
71. R.M. Stenberg, J. Fortney, S.W. Barlow, B.P. Magrane, J.A. Nelson, and P. Ghazal Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains J. Virol. 64 1990 1556 1565
72. M.F. Stinski, D.R. Thomsen, R.M. Stenberg, and L.C. Goldstein Organization and expression of the immediate early genes of human cytomegalovirus J. Virol. 46 1983 1 14
73. D.N. Streblow, S.L. Orloff, and J.A. Nelson Do pathogens accelerate atherosclerosis? J. Nutr. 131 2001 2798S 2804S
74. D.R. Thomsen, R.M. Stenberg, W.F. Goins, and M.F. Stinski Promoter-regulatory region of the major immediate early gene of human cytomegalovirus Proc. Natl. Acad. Sci. U.S.A. 81 1984 659 663
75. X. Wang, D.Y. Huang, S.M. Huong, and E.S. Huang Integrin αvβ3 is a coreceptor for human cytomegalovirus Nat. Med. 11 2005 515 521
76. E.A. White, C.L. Clark, V. Sanchez, and D.H. Spector Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression J. Virol. 78 2004 1817 1830
77. H.M. Wu, K.H. Chi, and W.W. Lin Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production FEBS Lett. 526 2002 101 105
78. M.J. Yin, Y. Yamamoto, and R.B. Gaynor The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β Nature 396 1998 77 80
79. A.D. Yurochko, and E.S. Huang Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression J. Immunol. 162 1999 4806 4816
80. A.D. Yurochko, T.F. Kowalik, S.M. Huong, and E.S. Huang Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters J. Virol. 69 1995 5391 5400
81. A.D. Yurochko, E.S. Hwang, L. Rasmussen, S. Keay, L. Pereira, and E.S. Huang The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection J. Virol. 71 1997 5051 5059
82. A.D. Yurochko, M.W. Mayo, E.E. Poma, A.S. Baldwin Jr., and E.S. Huang Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters J. Virol. 71 1997 4638 4648
83. J. Zhu, A.A. Quyyumi, J.E. Norman, G. Csako, and S.E. Epstein Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels J. Am. Coll. Cardiol. 34 1999 1738 1743